EUnetHTA Conference 2014 - HTA 2.0 Europe – Teaming Up for Value (Roma, Oct. 30-31, 2014)
Opening plenary: HTA, regulation and policy making – Synergy in focus
Cooperation and exchange of information between HTA organisations in Europe and globally has taken place for quite some time. However, recently European HTA witnessed a significant increase in the level of organisation, intensity and coherence of joint efforts such as producing HTA information together, engaging with the HTA process stakeholders, and establishing working relationship with the regulators. Efforts are made to develop sustainable strategic interaction with policymakers on matters regarding assessment and access to health technologies. Both the European Commission and individual EU Member States have been instrumental in supporting these efforts which the European HTA organisations themselves initiated more than a decade ago.
This session will bring you up-to-date on the key objectives, achievements and trends in the European HTA cooperation efforts from the point of view of the national healthcare system of the EU Member State, the European Commission and the European regulatory bodies.
Hon. Beatrice Lorenzin, Minister of Health, Ministry of Health, Rome, Italy, (TBC)
Andrzej Rys, Director for Health Systems and Products, DG Health and Consumers, European Commission
Finn Børlum Kristensen, Director, EUnetHTA Secretariat, Danish Health and Medicines Authority, Copenhagen, Professor, Health Services Research and HTA, University of Southern Denmark, Odense, Denmark
Guido Rasi, Executive Director, European Medicines Agency (EMA)
Wolfgang Ecker, Chair of Working Group on Clinical Investigation and Evaluation (Medical device legislation), European Commission; Head of Department III/3, Pharmaceuticals and Medical Devices, Blood, Tissue and Transplantation, Federal Ministry of Health, Vienna, Austria